Skip to main
PRE

PRE Stock Forecast & Price Target

PRE Analyst Ratings

Based on 4 analyst ratings
Strong Buy
Strong Buy 75%
Buy 25%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Prenetics Global is positioned for strong growth with its focus on science-backed products, increasing revenue and financing deals, innovative marketing strategies, and expansion plans. With high projected retention rates and strong financials, the stock's current lower multiple presents an attractive entry point for potential investors. The company's commitment to continuously expanding and improving their product line makes them a promising choice for long-term investment.

Bears say

Prenetics Global is currently using a significant portion of their cash balance for share buybacks, which may not be a sustainable use of funds. The company's growth potential is highly reliant on successfully converting customers into paying subscribers and maintaining subscriber retention rates. However, if consumer preferences shift or macroeconomic conditions change, the company's revenue and operating results could be negatively impacted. Additionally, the company's shift towards quarterly subscription plans may not be enough to significantly improve customer lifetime value and drive sustainable growth.

PRE has been analyzed by 4 analysts, with a consensus rating of Strong Buy. 75% of analysts recommend a Strong Buy, 25% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Prenetics Global Ltd and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Prenetics Global Ltd (PRE) Forecast

Analysts have given PRE a Strong Buy based on their latest research and market trends.

According to 4 analysts, PRE has a Strong Buy consensus rating as of Sep 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $34.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $34.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Prenetics Global Ltd (PRE)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.